TTI-0102

· Thiogenesis Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TTI-0102, covering 2025-07-11 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess TTI-0102 vs Placebo in MELAS Patients [Phase 2]